Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
89,16 USD | -1,06% | +2,81% | +16,92% |
Attività
- valvole cardiache e prodotti chirurgici (67,9%);
- sistemi di monitoraggio emodinamico (15,5%);
- altro (16,6%): cateteri a palloncino, impianti artificiali, ecc.
Le vendite nette sono distribuite geograficamente come segue: Stati Uniti (58,4%), Europa (22,2%), Giappone (7,6%) e altro (11,8%).
Numero di dipendenti: 19 800
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta | ||
---|---|---|---|---|---|---|---|
Transcatheter Mitral and Tricuspid Therapies
64,6
%
| 3 518 | 65,4 % | 116 | 2,2 % | 3 880 | 64,6 % | +3.241,77% |
Surgical Heart Valve Therapy
16,6
%
| 893 | 16,6 % | 999 | 16,6 % | +11,89% | ||
Critical Care
15,5
%
| 855 | 15,9 % | 928 | 15,5 % | +8,55% | ||
Transcatheter Mitral and Tricuspid Therapies
3,3
%
| 3 518 | 65,4 % | 116 | 2,2 % | 198 | 3,3 % | +70,20% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
58,4
%
| 3 133 | 58,2 % | 3 509 | 58,4 % | +12,01% |
Europe
22,2
%
| 1 175 | 21,8 % | 1 335 | 22,2 % | +13,59% |
Rest of World
11,8
%
| 601 | 11,2 % | 709 | 11,8 % | +17,92% |
Japan
7,5
%
| 474 | 8,8 % | 452 | 7,5 % | -4,48% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Chief Executive Officer | 56 | 01/01/15 | |
Scott Ullem
DFI | Director of Finance/CFO | 57 | 01/01/14 |
Todd Brinton
CTO | Chief Tech/Sci/R&D Officer | - | 01/02/19 |
Investor Relations Contact | - | - | |
Tim Patz
SAM | Sales & Marketing | - | 01/07/05 |
Daveen Chopra
PRN | Corporate Officer/Principal | 45 | - |
Linda Park
LAW | General Counsel | 46 | - |
Corporate Officer/Principal | 66 | 01/07/17 | |
Tammy Perry
PRN | Corporate Officer/Principal | - | 01/07/11 |
Donald Bobo
PRN | Corporate Officer/Principal | 62 | 01/01/95 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Leslie Heisz
BRD | Director/Board Member | 63 | 05/07/16 |
Chairman | 67 | 13/11/14 | |
Steven Loranger
BRD | Director/Board Member | 72 | 16/03/16 |
Paul LaViolette
BRD | Director/Board Member | 66 | 13/07/20 |
Kieran Gallahue
BRD | Director/Board Member | 60 | 10/02/15 |
Ramona Sequeira
BRD | Director/Board Member | 58 | 07/05/20 |
Chief Executive Officer | 56 | 01/01/15 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 652 000 000 | 597 178 790 ( 91,59 %) | 49 400 000 ( 7,577 %) | 91,59 % |
Coordinate società
Società del gruppo
Nome | Categoria e settore |
---|---|
Edwards Lifesciences (India) Pvt Ltd.
Edwards Lifesciences (India) Pvt Ltd. Medical SpecialtiesHealth Technology Part of Edwards Lifesciences Corp., Edwards Lifesciences (India) Pvt Ltd. is an Indian company that designs, develops, manufactures and markets products to treat late-stage cardiovascular disease. The company is based in Mumbai, India. |
Medical Specialties
|
Edwards Lifesciences World Trade Corp.
Edwards Lifesciences World Trade Corp. Medical SpecialtiesHealth Technology Part of Edwards Lifesciences Corp., Edwards Lifesciences World Trade Corp. is an American company. The company is located in the US. |
Medical Specialties
|
Edwards Lifesciences Technology SARL
| |
Edwards Lifesciences AG
Edwards Lifesciences AG Medical SpecialtiesHealth Technology Part of Edwards Lifesciences Corp., Edwards Lifesciences AG is a Swiss company that manufactures and distributes healthcare equipment. The company is based in Nyon, Switzerland. |
Medical Specialties
|
Settore
Vendite per attività
Vendite per regione
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+16,92% | 53,72 Mrd | |
+12,15% | 227 Mrd | |
+14,90% | 197 Mrd | |
+18,22% | 141 Mrd | |
+29,15% | 110 Mrd | |
+0,53% | 64,15 Mrd | |
+6,33% | 51,75 Mrd | |
+10,93% | 45,2 Mrd | |
+5,87% | 37,37 Mrd | |
+27,06% | 32,11 Mrd |
- Borsa valori
- Azioni
- Azione EW
- Società Edwards Lifesciences Corporation